Developing story — details emerging. Check the source link for the latest updates.
Source: [Seeking Alpha](https://seekingalpha.com/article/4937404-vera-therapeutics-fdas-egfr-analysis-supports-a-speculative-buy?source=feed_all_articles)
Chris Kubasik was ousted as Lockheed Martin's incoming CEO in 2012 after what that company called "close personal relationship with a subordinate employee.
Developing story — details emerging. Check the source link for the latest updates.
Anthropic's revenue run rate is up about sevenfold from a year earlier.
Developing story — details emerging. Check the source link for the latest updates.
Developing story — details emerging. Check the source link for the latest updates.
We’ve seen three years in a row of double-digit gains. Will there be a fourth?